Aclaris Therapeutics to Present at the Morgan Stanley 2016 Healthcare Conference

MALVERN, Pa., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that Dr. Neal Walker, President & Chief Executive Officer, will present at the Morgan Stanley 2016 Global Healthcare Conference on Wednesday, September 14, 2016 at 11:05 a.m. EDT at the Grand Hyatt, New York, NY.

A live audio webcast of the Aclaris presentation can be accessed by visiting the “Investors” section of the Company’s website at A replay of the webcast will be archived on the Aclaris Therapeutics website for 30 days following the presentation date.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology. Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting Aclaris’ website at

Contact: Aclaris Contact Michael Tung, M.D. Vice President / Investor Relations 484-329-2140 Media Contact Mariann Caprino TogoRun 917-242-1087

Source:Aclaris Therapeutics, Inc.